Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum has approved the strategy and operating budget of the Dubai Longevity Authority, following the regulator's inaugural board meeting. The move gives the newly formed body its mandate to begin turning its founding legislation into working policy and licensed activity.
The Dubai Longevity Authority is described as the world's first dedicated regulator for the Longevity, Wellness and Advanced Health sector. It was established under Law No. (17) of 2026 and formally came into being on 6 June. The Authority operates under the Presidency of Sheikh Hamdan bin Mohammed and the Chairmanship of Helal Saeed Almarri, who is also Director General of the Dubai Department of Economy and Tourism.
What the Authority will regulate
The Dubai Longevity Authority has been given oversight of the full value chain in its sector, from research and clinical trials through sourcing, manufacturing, market delivery and commercialisation. That scope positions it as a single regulatory point for a sector spanning science, medicine and industry, rather than a body confined to one part of the process.
At its inaugural board meeting, members approved a strategy and operating budget centred on three priorities: accelerating regulatory development, pilot implementation, and market activation. As part of this work, the Authority has designed a Minimum Viable Product programme, intended as a controlled environment in which selected innovators can test and scale their work under supervision before wider rollout.
